FDA product code QDS: Mers-Cov And Common Respiratory Pathogens Semi-Quantitative And Quantitative Multiplex Nucleic Acid Detection System

QDS is the FDA product code for mers-cov and common respiratory pathogens semi-quantitative and quantitative multiplex nucleic acid detection system. It is a Class II device, regulated under 21 CFR 866.4001 and reviewed by the Microbiology panel. FDA has cleared 3 510(k) submissions under QDS, 2 in the last five years, from 2 different applicants. The average 510(k) review took 90 days (median 59); 30 days on average over the last three years. FDA has posted 6 recalls for QDS devices, 5 initiated in the last five years.

Definition

A Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and common respiratory pathogens qualitative, semi-quantitative or quantitative multiplex nucleic acid detection system is an in vitro diagnostic test for the detection, identification, and quantification of MERS-CoV and common respiratory pathogens – associated nucleic acids in human clinical specimens. The test is indicated for individuals meeting specific MERS-CoV clinical and/or epidemiological criteria. It aids in the differential diagnosis of MERS-CoV infection in conjunction with other clinical, epidemiologic, and laboratory data, in accordance with the guidelines provided by the appropriate public health authorities.

Classification

FieldValue
Device nameMers-Cov And Common Respiratory Pathogens Semi-Quantitative And Quantitative Multiplex Nucleic Acid Detection System
Device classClass II
Regulation21 CFR 866.4001
Review panelMI — Microbiology
Medical specialtyPathology
Premarket route510(k)

510(k) clearances per year for QDS

YearClearancesAvg. review days
20181181
2022159
2024130

Compare with all 510(k) review times · Search every QDS clearance

Top QDS applicants

ApplicantClearancesLatest
Biofire Diagnostics, LLC22022-10-27
Biofire Diagnostics, LLC (Biomerieux)12024-11-06

Most recent QDS clearances

510(k)ApplicantDeviceDecision dateReview days
K243222Biofire Diagnostics, LLC (Biomerieux)BIOFIRE® FILMARRAY® Pneumonia Panel (BIOFIRE Pneumonia Panel); BIOFIRE® FILMARRAY® Pneumonia Panel plus (BIOFIRE Pneumonia Panel plus)2024-11-0630
K222601Biofire Diagnostics, LLCFilmArray Pneumonia Panel plus2022-10-2759
K181324Biofire Diagnostics, LLCFilmArray Pneumonia Panel plus2018-11-15181

Recalls for QDS devices

6 product recalls in 5 recall events; 5 initiated in the last five years and 5 still open. Most recent: 2026-08-12.

YearRecalls
20211
20231
20242
20251
20261

Frequently asked questions

What is FDA product code QDS?

QDS is the FDA product code for mers-cov and common respiratory pathogens semi-quantitative and quantitative multiplex nucleic acid detection system. It is a Class II device, regulated under 21 CFR 866.4001 and reviewed by the Microbiology panel.

What device class is QDS?

Class II, regulation 21 CFR 866.4001. Typical premarket route: 510(k).

How long does a 510(k) take for product code QDS?

Across 3 cleared submissions the average was 90 days from receipt to decision (median 59).

Which companies have the most QDS clearances?

Biofire Diagnostics, LLC (2); Biofire Diagnostics, LLC (Biomerieux) (1).

Have QDS devices been recalled?

Yes: 6 product recalls across 5 recall events; the most recent began 2026-08-12.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times